ArticleClinical and molecular hepatology2022

Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial.

Ju Hee Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.